WAC 388-530-4000   Drug use review (DUR) board.  In accordance with 42 CFR 456.716, the department establishes a drug use review (DUR) board.

     (1) The DUR board:

     (a) Includes health professionals who are actively practicing and licensed in the state of Washington and who have recognized knowledge and expertise in one or more of the following:

     (i) The clinically appropriate prescribing of outpatient drugs;

     (ii) The clinically appropriate dispensing and monitoring of outpatient drugs;

     (iii) Drug use review, evaluation, and intervention; and

     (iv) Medical quality assurance.

     (b) Is made up of at least one-third but not more than fifty-one percent physicians, and at least one-third pharmacists.

     (2) The department may appoint members of the pharmacy and therapeutics committee established by the health care authority (HCA) under chapter 182-50 WAC or other qualified individuals to serve as members of the DUR board.

     (3) The DUR board meets periodically to:

     (a) Advise the department on drug use review activities;

     (b) Review provider and patient profiles;

     (c) Review scientific literature to establish evidence-based guidelines for the appropriate use of drugs, including the appropriate indications and dosing;

     (d) Recommend adoption of standards and treatment guidelines for drug therapy;

     (e) Recommend interventions targeted toward correcting drug therapy problems; and

     (f) Produce an annual report.

     (4) The department has the authority to accept or reject the recommendations of the DUR board in accordance with 42 CFR 456.716(c).



[Statutory Authority: RCW 74.04.050, 74.08.090, 74.09.530, and 74.09.700. 07-20-049, § 388-530-4000, filed 9/26/07, effective 11/1/07.]